However, overexpression of TET catalytic domains to activate TET enzyme activity was found to significantly improve AD pathology such as toxic Aβ peptide clearance and tau hyperphosphorylation reduction, as well as synaptic dysfunction amelioration [90]. Here, MAPT is linked to Alzheimer disease.